La medicine of tomorrow It is being built today in quiet laboratories, technology-filled clinics, and cutting-edge research centers around the world. What a few years ago sounded like science fiction—genome-based therapies, almost tailor-made drugs, or hyper-connected operating rooms—is beginning to become part of the daily lives of many healthcare professionals.
Meanwhile, the public lives with this revolution almost without realizing it: they tell us about big Data, Artificial Intelligenceprecision medicine or immunotherapy And yet, we continue to go to our family doctor. Understanding what's happening behind the scenes helps put into context news about advances against cancer, digital health record platforms, or genetic projects that promise to forever change how we prevent diseases.
Today's science to design the medicine of the future
Centers such as IDIBAPS or IRB Barcelona are promoting a internationally competitive biomedical researchThese institutes, with scientific programs ranging from basic molecular biology to clinical applications, organize their work into broad thematic areas—such as cancer, metabolic diseases, neuroscience, or immunology—which are coordinated into highly specialized projects, often invisible to the general public.
To bring this reality closer to society, IRB Barcelona has promoted the series of meetings “Science today for the medicine of tomorrow”, within the BARCELONA BIOMED PERSPECTIVES series. These conferences are designed precisely to explain in an understandable way what the current challenges of research are, what is being achieved and how that knowledge will translate into better diagnoses and treatments in a few years.
Researchers are working with pathologies that still pose a huge challenge. clinical challenge: aggressive tumors, neurodegenerative diseasesAutism spectrum disorders, obesity and diabetes, or problems related to skin aging, to name just a few examples. Although giant strides have been made, many of these conditions still lack curative solutions or have clearly improvable survival rates and quality of life.
The use of new technological tools —massive DNA sequencing, genomic data analysis, complex mathematical models, biomedical big data— has radically changed the way these diseases are studied. It is no longer just about observing symptoms and measuring isolated parameters; now millions of data points per patient are analyzed, compared with enormous global databases, and patterns are sought that allow us to anticipate the development of the disease or choose the optimal treatment.
Much of this work is carried out in what is known as basic investigationAt first glance it may seem far removed from a medical consultation, but it is precisely there where discoveries are made that, over time, end up becoming drugs. biomarkers or new diagnostic techniques. Hence the motto of IRB Barcelona: “the medicine of the future starts here”, reminding us that without solid laboratory science there is no possible innovation in hospitals.
Cutting-edge advances: from cancer to obesity to aging
In recent years, research groups linked to institutes such as IRB Barcelona have played a leading role findings of international significance These approaches point to new ways of addressing various diseases. One of the most active fields is immunotherapy for particularly aggressive colon tumors, a strategy that seeks to "awaken" the patient's own immune system so that it recognizes and attacks cancer cells.
Another open front is the fight against metastasisMetastasis is responsible for the majority of cancer-related deaths. Understanding what signals cause certain tumor cells to leave the original tumor and settle in other organs is key to designing treatments that stop this process in its tracks. Researchers are analyzing molecules, signaling pathways, and genetic changes that could act as "switches" on metastasis.
Unexpected ways are also being explored to get certain drugs to the brain by bypassing the blood brain barrierThis is a kind of biological filter that protects the central nervous system but, at the same time, hinders the access of potentially useful drugs. Some groups have drawn inspiration from animal venoms—such as those of certain snakes or insects—to decipher how they penetrate this barrier and, from there, develop new therapeutic strategies.
Beyond cancer, research is focusing on processes such as skin agingThis process not only has an aesthetic dimension but also involves changes in the skin's barrier function and healing capacity. Understanding why the skin ages at a cellular and molecular level can help improve treatments for chronic wounds, inflammatory skin diseases, or even the transdermal delivery of drugs.
Another prominent line of inquiry focuses on to trace the role of certain genes involved in autismas well as delving deeper into the biological links between obesity and diabetes. In the latter case, the studies seek to clarify how excess adipose tissue alters glucose and lipid metabolism, and how interventions could be made before serious complications such as type 2 diabetes or associated cardiovascular diseases appear.
Human genetics: the 0,1% of DNA that makes the difference
One of the most profound changes in modern medicine comes from the human geneticsIt is estimated that only around 0,1% of our DNA is different between people, but in that small fraction lies a good part of what makes us unique: eye color, height, physical features… and, what is even more relevant from a medical point of view, our vulnerability to diseases, the way we metabolize drugs or the probability of responding well to a treatment.
From the discovery of the structure of DNA to the complete sequencing of the human genomeGenetics has gone from being an almost abstract laboratory concept to an incredibly useful clinical tool. Today, many hospitals perform genetic studies to clarify uncertain diagnoses, identify carriers of inherited mutations, or adjust medication based on certain genetic variants.
In this context, professionals such as the Dr. Encarna GuillénThe head of the Genetics Department at Sant Joan de Déu Hospital in Barcelona, a university professor, and president of the Spanish Association of Human Genetics, play an essential role. These specialists explain how genetics is transforming disease prediction and prevention, as well as the ability to diagnose and treat rare diseases that previously went unexplained.
Genetics opens the door to a more predictive and preventive medicineIt is possible to identify individuals at high risk of developing certain cancers or cardiovascular diseases and offer them follow-up programs or lifestyle changes before the problem arises. Similarly, genetic analysis helps select the most appropriate drug and optimal dosage, reducing side effects and increasing the effectiveness of treatments.
However, this revolution also raises ethical and social challenges Top-tier. Questions arise about who should have access to genetic information, how to protect data privacy, how to prevent genome-based discrimination, and what to do when variants of uncertain significance are detected. The medicine of tomorrow is not only more technological, but also demands a profound social debate and robust legal frameworks.
Personalized and precision medicine: treatment tailored to the patient
The combination of genetics, molecular biology, and massive data analysis is giving rise to what is called personalized or precision medicineThe goal is to move beyond the "one size fits all" approach—the same treatment for all patients with the same diagnosis—and advance towards therapies tailored to each person's individual characteristics, from their genetic profile to their environment and lifestyle habits.
In the field of cancer, this approach translates into studying the specific molecular alterations that drive tumor growth and use that information to select drugs targeting those specific targets. Thus, two people with the “same” type of cancer according to the classic classification can receive completely different treatments depending on the mutations detected in their tumor.
A clear example is the project “New personalized medicine strategy for glioblastoma multiforme“,” led by Dr. Lorea Blázquez at the Biodonostia Health Research Institute. Glioblastoma multiforme is the most common brain cancer in adults and one of the most aggressive, with still very limited treatment options and low survival rates. This is precisely why it has become a priority in cancer research.
The Lab AECC 2021 grant of 246.800 euros awarded to this researcher allows consolidate a young research group The research focuses on identifying the specific alterations that promote the development and progression of glioblastoma. The idea is to use these alterations as therapeutic targets, that is, as specific points on which new treatments can act to block tumor growth.
This project pays special attention to changes detected in the Messenger RNAMessenger RNA (mRNA) is the molecule that translates the information from DNA so that cells can "read" it and produce the corresponding proteins. For the message to be correct, mRNA undergoes a process called splicing, in which different parts of the molecule are cut and assembled in a precise order. When this process is disrupted, abnormal versions of proteins are generated, which can contribute to the initiation and growth of a tumor.
Blázquez's team focuses precisely on studying these splicing alterations in glioblastoma and exploring ways to correct them through new therapiesThis is a very promising line of research, because it allows us to attack one of the underlying mechanisms that make this type of brain tumor so resistant and aggressive.
The key role of funding and outreach in cancer
Cutting-edge projects like the glioblastoma one would be impossible without Specific funding for cancer researchThe Spanish Association Against Cancer (AECC) and its Gipuzkoa branch play a fundamental role in supporting emerging teams, such as that of Dr. Blázquez, through competitive calls that select projects of high scientific quality.
At an event held at the Gipuzkoa Active Space Against Cancer, the researcher explained in detail her work and how this financial aid will allow to promote new strategies for personalized and precision medicine for the treatment of glioblastoma multiforme. The presentation was given by Nora Sagarzazu and had a clear educational objective: to bring the research closer to the public and show the real impact of donations.
The Cancer Association in Gipuzkoa emphasized a powerful message: “Today’s research is tomorrow’s medicine”These words perfectly summarize the importance of sustained investment in science, as the results not only benefit current patients but also future generations, offering more accurate diagnoses and better-targeted treatments.
In the last year analyzed alone, this provincial association allocated almost 400.000 euros to various research projects These initiatives arose within the region thanks to contributions from members, individuals, businesses, and donors. Beyond financial support, the organization brings together patients, families, volunteers, and professionals who work together on prevention, awareness, support, and funding for innovative research.
During 2020, the Cancer Foundation in Gipuzkoa assisted approximately 1.270 people affected by the diseaseincluding patients and their families. The association also points out that it maintains six offices throughout the province and that all the services it offers—information, psychological support, social guidance, workshops, etc.—are completely free, an essential resource while science advances.
Digital transformation and technological platforms at the service of health
Beyond the laboratories, the The revolution in tomorrow's medicine is also noticeable in the consultation room. and in the daily management of health centers, clinics, and hospitals. Digital transformation is rapidly changing the way healthcare professionals work, with direct impacts on efficiency, quality of care, and patient experience.
The healthcare sector has been one of the biggest beneficiaries of the emergence of new technologies: electronic health records, telemedicine platforms, online appointment systems, data analysis tools, administrative automation… Although it may seem like a “office” change, the truth is that Optimizing internal processes frees up time so that doctors and nurses can focus on what's important: direct contact with people.
Solutions like Siku These examples perfectly illustrate this trend. It's a platform that integrates features such as electronic patient records, automated billing, and advanced appointment scheduling. The idea is to reduce the bureaucratic burden that often overwhelms clinics, as well as decrease errors and duplicate documentation.
In the field of telemedicineSiku allows for the organized management of remote appointments, with automatic reminders and customization options based on the specialty or the professional's preferences. This facilitates the monitoring of chronic patients, the resolution of simple consultations without unnecessary travel, and greater convenience for those who live far from healthcare centers.
Data security is another pillar of this transformation. The use of technologies such as blockchain and secure platforms It is gaining traction to ensure that clinical information travels with the maximum possible protection, complying with regulations and respecting privacy. Siku, for example, is committed to a secure yet interoperable electronic health record, capable of connecting with other healthcare software tools to ensure continuity of care.
Personalized medicine, data analysis, and digital dentistry
The availability of large volumes of clinical information and the ability to analyze them intelligently are leading to a increasingly data-driven medicinePlatforms like Siku not only store medical records; they also offer statistics and reporting modules that help professionals evaluate how their practice is performing, what types of cases they handle most frequently, or where they can improve management.
From this perspective, personalized medicine is not based solely on genetics, but also on... organization and exploitation of medical dataKnowing which therapies have worked best in similar patient profiles, or what patterns are observed in the evolution of certain pathologies, allows for care that is more tailored to individual needs.
Dentistry is one of the fields where the technological revolution is especially visible. Tools such as the Print 3D They have changed the way prostheses, splints, and other devices are manufactured, reducing waiting times and improving fit. At the same time, detailed digital records of the patient's mouth allow for more precise planning of complex treatments.
Siku incorporates modules specifically designed for the dental practicesuch as the digital periodontogram or the management of referrals to dental laboratories. These functions simplify daily work, prevent loss of information, and facilitate communication between the clinic and the laboratories, all with a positive impact on the patient experience.
The systematic analysis of data with statistical and reporting tools also facilitates a more strategic management of the consultationIt allows for the detection of bottlenecks, adjustment of schedules, review of waiting times, and evaluation of the performance of different services. All of this contributes to a more efficient and sustainable care model, aligned with the demands of the medicine of the future.
Between cookies, privacy and digital ethics in health
The intensive use of online platforms and remote access to clinical information makes it essential to pay attention to aspects such as the privacy, consent and the processing of personal dataMany health websites incorporate cookie notices that explain what information is collected, for what purposes, and how the user can accept or reject certain types of tracking.
In general, cookies considered necessary are stored because they are essential for basic operation of the website (for example, to maintain a logged-in session or remember certain preferences). Other cookies, however, are used to analyze how people navigate the site, with the aim of improving content and services. These latter cookies are usually optional and require explicit consent.
Reputable websites in the healthcare sector usually offer the possibility of reject non-essential cookiesHowever, they cautioned that this decision may affect certain functionalities or the smoothness of navigation. It's a complex balance between leveraging the advantages of web analytics and respecting user autonomy and privacy as much as possible.
These types of policies reflect a broader debate about the Digital ethics in medicineHow to manage electronic health records, what security measures to implement, who can access what type of data, and how to prevent misuse of health information. The medicine of tomorrow depends not only on brilliant algorithms but also on clear rules and effective control mechanisms.
In this context, it is crucial that both professionals and patients become familiar with data protection concepts, informed consent in digital environments, and the rights of access, rectification, or erasure of personal information. Trust in new technological tools inevitably depends on transparent and responsible data management.
Looking at the combination of all these elements—high-level basic research, concrete projects in cancer and genetics, digital platforms like Siku, telemedicine, data analysis, and careful privacy policies—a picture emerges Tomorrow's medicine will be much more precise, connected, and person-centered.What is born today in a microscope, in a line of code, or in the waiting room of a patient association will, over time, translate into faster diagnoses, better-targeted treatments, and more humane healthcare supported by the best available science.
